Intrinsic value of Denali Therapeutics Inc. (DNLI)
Live fair value data for Denali Therapeutics Inc. (DNLI) is currently unavailable. Please check again shortly.
Current Price: $275.00
Valuation: Undervalued
Confidence: 8.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Denali Therapeutics Inc. (DNLI) undervalued or overvalued?
Based on the current model output, Denali Therapeutics Inc. appears to be undervalued with a upside of 43.00%.
Fair value vs market price — Denali Therapeutics Inc. (DNLI)
Unlock premium access to view the live fair value comparison against current market price for DNLI.
Frequently Asked Questions - DNLI
How is DNLI intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for DNLI.
Is DNLI undervalued or overvalued right now?
DNLI is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for DNLI: open their intrinsic value pages.